LifeVantage (NASDAQ:LFVN) vs. Pharming Group (OTCMKTS:PHGUF) Critical Survey

LifeVantage (NASDAQ:LFVN – Get Rating) and Pharming Group (OTCMKTS:PHGUF – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

Volatility & Risk

LifeVantage has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500. Comparatively, Pharming Group has a beta of 1.1, meaning that its stock price is 10% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and price targets for LifeVantage and Pharming Group, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeVantage	0	0	0	0	N/A
Pharming Group	0	0	0	0	N/A

Valuation and Earnings

This table compares LifeVantage and Pharming Group’s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeVantage	$206.36 million	0.21	$3.12 million	($0.05)	-67.60
Pharming Group	$198.87 million	4.00	$16.00 million	$0.04	30.51

Pharming Group has lower revenue, but higher earnings than LifeVantage. LifeVantage is trading at a lower price-to-earnings ratio than Pharming Group, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

29.7% of LifeVantage shares are owned by institutional investors. 6.8% of LifeVantage shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares LifeVantage and Pharming Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
LifeVantage	-0.35%	5.21%	2.42%
Pharming Group	14.90%	15.52%	7.77%

Summary

Pharming Group beats LifeVantage on 7 of the 11 factors compared between the two stocks.

About LifeVantage

(Get Rating)

LifeVantage Corp. engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and personal care products. The firm operates through the following geographical segments: Americas Region, and Asia/Pacific and Europe Region. Its products include Protandim, LifeVantage Omega+ and ProBio, TrueScience and Petandim for dogs. The company was founded in June 1988 and is headquartered in Sandy, UT.

About Pharming Group

(Get Rating)

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following geographical segments: the United States, Europe, and Rest of the World. The company was founded on November 11, 1988 and is headquartered in Leiden, the Netherlands.